e-learning
resources
Paris 2018
Monday, 17.09.2018
Roles of innate lymphoid cells in asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prostaglandin E2 suppresses the function of human group 2 innate lymphoid cells
J. Mjösberg (Stockholm, Sweden)
Source:
International Congress 2018 – Roles of innate lymphoid cells in asthma
Session:
Roles of innate lymphoid cells in asthma
Session type:
Hot topics
Number:
3257
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Mjösberg (Stockholm, Sweden). Prostaglandin E2 suppresses the function of human group 2 innate lymphoid cells. International Congress 2018 – Roles of innate lymphoid cells in asthma
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Year: 2018
Generation and activation of myeloid derived suppressor cells using prostaglandin E2 and EP receptor agonists in vitro
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019
Prostaglandin D
2
induces
MUC5B
gene expression via DP1 in human airway epithelial cells
Source: Annual Congress 2010 - Lung cell biology and immunology
Year: 2010
Activation of E-prostanoid4 and E-prostanoid2 receptors inhibits TNF-α release from human alveolar macrophages
Source: Eur Respir J 2007; 29: 986-994
Year: 2007
Effects on cytokine expression in human plasmacytoid dendritic cells by prostaglandin I2 analogs
Source: Annual Congress 2009 - Translational models of lung disease
Year: 2009
NF-κB-dependent cytokine production is abolished by cyclopentenone prostaglandins in lung epithelial cells
Source: Eur Respir J 2001; 18: Suppl. 33, 354s
Year: 2001
LSC Abstract – High mobility group box 1 modulates lung innate immunity by promoting wound healing and cytokine release in human bronchial epithelial cells
Source: International Congress 2015 – Airway remodelling: recent developments
Year: 2015
Over-expression of SIGIRR attenuates TLR 4,5,9-mediated immune responses in human airway epithelial cells
Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Year: 2009
Arginine levels regulate pro-inflammatory mediator responses by lung epithelial cells
Source: Eur Respir J 2005; 26: Suppl. 49, 554s
Year: 2005
Profibrotic function of pulmonary group 2 innate lymphoid cells is controlled by regnase-1
Source: Eur Respir J, 57 (3) 2000018; 10.1183/13993003.00018-2020
Year: 2021
5-Hydroxytryptamine modulates migration, cytokine and chemokine release and T-cell priming capacity of human dendritic cells
Source: Annual Congress 2009 - Airway cell biology
Year: 2009
Fevipiprant is superior to montelukast in suppressing type 2 cytokine production from mast cell stimulated human Th2 cells
Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases
Year: 2019
Fevipiprant inhibits eosinophil activation induced by multiple metabolites of prostaglandin D2
Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses
Year: 2019
COX-1 driven biosynthesis of PGD2 during activation of human mast cells prevents formation of other prostanoids
Source: Virtual Congress 2020 – Novel molecular markers and targets for asthma phenotypes
Year: 2020
Protease activated receptor 2 (PAR2) antagonism reduces pro-inflammatory cytokine production in bronchial epithelial cells
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020
Leukotriene E4 affects expression of genes involved in inflammatory, remodelling and mitogenic responses in human bronchial epithelial cells
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016
Oral Presentation: Endogenous transforming growth factor influences rhinovirus replication in primary bronchial epithelial cells by suppressing the innate immune response
Source: Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease
Year: 2011
Double-stranded RNA upregulates TLR3 and induces pro-inflammatory, and innate immune cytokine expression in human bronchial smooth muscle cells
Source: Annual Congress 2010 - Airway smooth muscle cells
Year: 2010
CSE exposure abrogates regulatory effects of the bronchial epithelium on B cell survival and IgA production in a coculture system. A pivotal role of TACI
Source: Annual Congress 2012 - Cell culture and animal models of lung disease
Year: 2012
Human CD40 ligand-expressing type 3 innate lymphoid cells induce interleukin (IL)-10-producing immature transitional regulatory B-cells
Source: International Congress 2018 – Roles of innate lymphoid cells in asthma
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept